Mirion Technologies (MIR)

• Market cap: $4.16B
• 1 day: 1.82%
• 5 days: -1.54%
• 1 month: 11.33%
• 3 months: 67.51%
• 6 months: 67.51%
• Year to date: 75.56%
• 1 year: 76.08%
• 5 years: 79.80%
• 10 years: 79.80%
• Sector: Industrials
• Industry: Measuring & Controlling Devices

About: Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment.

Employees: 3,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

200% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 3 (+2) [Q3]

125% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 16

66% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 44

13% more funds holding

Funds holding: 157 [Q2] → 177 (+20) [Q3]

6% more capital invested

Capital invested by funds: $2.14B [Q2] → $2.27B (+$133M) [Q3]

0.47% more ownership

Funds ownership: 90.53% [Q2] → 91.01% (+0.47%) [Q3]

68% less call options, than puts

Call options by funds: $432K | Put options by funds: $1.35M

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $14 22% downside
• Avg. target: $19.25 8% upside
• High target: $22 23% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Baird Robert Mason 54% 1-year accuracy 7 / 13 met price target	23% upside $22	Outperform Initiated	19 Dec 2024
Goldman Sachs Joe Ritchie 70% 1-year accuracy 19 / 27 met price target	17% upside $21	Buy Maintained	12 Dec 2024
Citigroup Andrew Kaplowitz 61% 1-year accuracy 41 / 67 met price target	12% upside $20	Buy Maintained	4 Dec 2024
B. Riley Securities Yuan Zhi 22% 1-year accuracy 2 / 9 met price target	22% downside $14	Buy Initiated	26 Sept 2024